Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD

Blood

Volumn 107, Issue 4, 2006, Pages 1717-1723

  Rieger, Kathrin ^a   Loddenkemper, Christoph ^b   Maul, Jochem ^b   Fietz, Thomas ^b   Wolff, Daniel ^b   Terpe, Harald ^b   Steiner, Beate ^b   Berg, Erika ^b   Miehlke, Stephan ^b   Bornhäuser, Martin ^b   Schneider, Thomas ^b   Zeitz, Martin ^b   Stein, Harald ^b   Thiel, Eckhard ^b   Duchmann, Rainer ^b   Uharek, Lutz ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGRAFT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIVERTICULITIS; EFFECTOR CELL; ENZYME IMMUNOASSAY; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTESTINE BIOPSY; INTESTINE MUCOSA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UPREGULATION;

EID: 32644448124     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-06-2529     Document Type: Article

References (36)

1. + suppressor T cells. J Exp Med. 2001;193:F41-F45.
2. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory T cells mediate dominant transplantation tolerance. J Immunol. 2002;168:5558-5565.
3. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol. 2001;166:3789-3796.
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
5. + regulatory T cells. Nat Immunol. 2003;4:330-336.
6. + T regulatory cells. Nat Immunol. 2003;4:337-342.
7. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol. 2004;16:1643-1656.
8. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-1164.
9. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol. 2002;168:1080-1086.
10. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 1998;160:1212-1218.
11. high T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868-1878.
12. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002;196:401-406.
13. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493-3499.
14. Hoffmann P, Ermann J, Edinger M, Fathmann CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-399.
15. Colson YL, Christopher K, Glickman J, Taylor KN, Wright R, Perkins DL. Absence of clinical GvHD and the in vivo induction of regulatory T cells following facilitating cell transplantation. Blood. 2004;104:3829-3835.
16. + immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant. 2002;8:525-535.
17. high regulatory T cells. Blood. 2004;103:2410-2416.
18. Miura Y, Thoburn J, Bright E, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood. 2004;104:2187-2193.
19. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man: a clinicopathologic study of the rectal biopsy. Am J Surg Pathol. 1979;3:291-299.
20. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GvHD grading. Bone Marrow Transplant. 1995;15:825-828.
21. Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GvHD. Biol Blood Marrow Transplant. 2002;8:32-39.
22. Schneider T, Ullrich R, Bergs C, Schmidt W, Riecken EO, Zeitz M. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection: The Berlin Diarrhea/Wasting Syndrome Study Group. Clin Exp Immunol. 1994;95:430-435.
23. high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-1253.
24. Weisdorf SA, Roy J, Snover D, Platt JL, Weisdorf DJ. Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis. Bone Marrow Transplant. 1991;7:297-301.
25. Forbes GM, Erber WN, Herrmann RP, Davies JM, Collins BJ. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation. J Clin Pathol. 1995;48:308-313.
26. Sviland L, Pearson AD, Green MA, et al. Immunopathology of early graft-versus-host disease: a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients. Transplantation. 1991;52:1029-1036.
27. + T cells in thymus, cord and adult blood. Immunology. 2002;106:190-199.
28. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215-223.
29. Zeng D, Hoffmann P, Lan F, Huie P, Higgins J, Strober S. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood. 2002;99:1449-1457.
30. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107:1398-1407.
31. + T cells promote engraftment and tolerance following MHC-mismatch hematopoietic cell transplantation. Blood. 2005;105:1828-1836.
32. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versushost disease after bone marrow transplantation. Nat Med. 2003;9:1144-1150.
33. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112:1688-1696.
34. + T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant. 2003;9:243-256.
35. + (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol. 2004;126:697-703.
36. Stanzani M, Martins SLR, Saliba RM, et al. CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versushost disease after HLA-identical stem cell transplantation in humans. Blood. 2004;103:1140-1146.